11 Best Guru Stocks to Buy According to Wall Street Analysts

Page 4 of 10

7. MoonLake Immunotherapeutics (NASDAQ:MLTX)

Number of Hedge Fund Holders: 32

Average Upside Potential: 109.04%

MoonLake Immunotherapeutics (NASDAQ:MLTX) is a Swiss clinical-stage biopharmaceutical company focused on developing therapies for inflammatory diseases. The company’s lead candidate, Sonelokimab, targets conditions like Hidradenitis Suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. With an average upside potential of 109% as of April 18, MoonLake Immunotherapeutics (NASDAQ:MLTX) is one of the best Guru stocks to purchase.

On April 4, Cantor Fitzgerald reiterated an Overweight rating on MoonLake Immunotherapeutics (NASDAQ:MLTX). The analyst observed that the company has had strong success with its drug, Bimzelx, used to treat Hidradenitis Suppurativa, showing a 60% quarter-over-quarter prescription growth. Due to the potential of Bimzelx, analysts predict a significant upside from its current stock price of $38.06.

In the fourth quarter of 2024, MoonLake Immunotherapeutics (NASDAQ:MLTX) initiated two Phase 3 trials for psoriatic arthritis, one focusing on patients who have not used biologics before, and another targeting those who do not respond well to TNF treatments. Early in 2025, the company launched three more trials using their Nanobody therapy, Sonelokimab, for adolescent hidradenitis suppurativa (HS), palmoplantar pustulosis (PPP), and axial spondyloarthritis (axSpA). By the end of December 2024, MoonLake Immunotherapeutics (NASDAQ:MLTX) had $448 million in cash and short-term investments, down $46 million from the previous quarter, mostly due to increased spending on clinical trials.

According to Insider Monkey’s fourth quarter database, 32 hedge funds were bullish on MoonLake Immunotherapeutics (NASDAQ:MLTX), compared to 27 funds in the prior quarter. Mark Lampert’s Biotechnology Value Fund was the top stakeholder of the company, with 19.75 million shares valued at over $1 billion.

Page 4 of 10